ArticleBriefings in bioinformatics2026
METEOR: a data-adaptive Mendelian randomization method for powerful detection of shared and specific exposures underlying multiple outcomes.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Accurate identification of causal exposures for multimorbidity can benefit the co-prevention and co-management of multiple-related outcomes. This goal can be conceptually addressed within a multi-outcome Mendelian randomization (MR) framework. However, existing multi-outcome MR methods suffer from restrictions on format and availability of data inputs, fail to account for the potential sample overlap, rely on pre-selected independent instrumental variables (IVs), and are unable to account for horizontal pleiotropy. Here, we propose METEOR, a novel MR method that jointly models one exposure and multiple outcomes to identify both shared and outcome-specific causal exposures. METEOR accounts for sample overlap between exposure and outcomes, allows outcomes from different genome-wide association studies (GWAS) datasets, self-adaptively determines IVs from correlated single-nucleotide polymorphisms, and explicitly models horizontal pleiotropy. Using summary statistics, METEOR infers causal effects under a joint-likelihood framework with a scalable, sampling-based algorithm. Simulations show that METEOR presents well-calibrated $P$-values for both global and single-outcome tests, and achieves average power improvements of 55.33% and 56.50% over five existing MR methods in the global and single tests, respectively. In real data applications, METEOR produces the most accurate causal effect estimates in positive control analyses, reduces false positives by 18.75% in negative control analyses, and highlights that controlling BMI could benefit the co-management of multiple cardiovascular diseases (CVDs) and multiple gastrointestinal (GI) diseases, while controlling blood pressure could benefit the co-management of multimorbidity across CVDs and mental disorders (MDs), as well as across GI diseases and MDs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.